Alternative splicing of exon 37 of FBN1 deletes part of an 'eight-cysteine' domain resulting in the Marfan syndrome

Clinical Genetics

Volumn 55, Issue 2, 1999, Pages 118-121

  McGrory, Joel ^a   Cole, William G ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Extracellular matrix; Protein module

Indexed keywords

CYSTEINE; GLYCINE; LYSINE; SERINE; THREONINE;

ALTERNATIVE RNA SPLICING; ARTICLE; CASE REPORT; CODON; EXON; GENE DELETION; HUMAN; HUMAN CELL; INTRON; MALE; MARFAN SYNDROME; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SKIN FIBROBLAST;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CHILD; CYSTEINE; EXONS; HUMANS; MALE; MARFAN SYNDROME; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; SEQUENCE DELETION;

EID: 0032983901     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1999.550208.x     Document Type: Article

References (19)

1. Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Molec Genet 1995: 4: 1799-1809.
2. Sakai LY, Keene DR, Glanville RW, Bachinger HP. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J Biol Chem 1991: 266: 14763-14770.
3. Pereira L, D'Alessio M, Ramirez F, Lynch JR, Sykes B, Pangilinan T, Bonadio J. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Molec Genet 1993: 2: 961-968.
4. Collod-Beroud G. Marfan database (third edition): new mutations and new routines for the software. Nucleic Acids Res 1998: 26229-26233.
5. Chan D, Cole WG. Low basal transcription of genes for tissue-specific collagens by fibroblasts and lymphoblastoid cells. J Biol Chem 1991: 266: 12487-12494.
6. Sanguinetti CJ, Neto ED, Simpson AJG. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotech 1994: 17: 915-918.
7. Kainulainen K, Karttunen L, Puhakka L, Sakai LY, Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nature Genet 1994: 6: 64-69.
8. Nijbroek G, Sood S, McIntosh I, Francomano CA, Bull E, Pereira L, Ramirez F, Pyeritz RR, Dietz HC. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet 1995: 57: 8-21.
9. Stephens RM, Schneider TD. Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J Mol Biol 1992: 228: 1124-1136.
10. Rogan PK, Faux BM, Schneider TD. Information analysis of human splice site mutations. Hum Mutat 1998: 12: 153-171.
11. Corson GM, Chalberg SC, Dietz HC, Charbonneau NL, Sakai LY. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5'end. Genomics 1993: 17: 476-484.
12. Dietz HC, McIntosh I, Sakai LY, Corson GM, Chalberg SC, Pyeritz RE, Francomano CA. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 1993: 17: 468-475.
13. Tynan K, Comeau K, Pearson M, Wilgenbus P, Levitt D, Gasner C, Berg MA, Miller CD, Francke U. Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. Hum Molec Genet 1993: 2: 1813-1821.
14. Ades LC, Haan EA, Colley AF, Richard RI. Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome. J Med Genet 1996: 33: 665-671.
15. Liu W, Qian C, Comeau K, Brenn T, Furthmayr H, Francke U. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome. Hum Mol Genet 1996: 5: 1581-1587.
16. Liu W. Qian C, Francke U. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nature Genet 1997: 16: 328-329.
17. McGookey Milewicz D, Pyeritz RE, Crawford ES, Byers PH. Marfan syndrome: defective synthesis, secretion and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest 1992: 89: 79-86.
18. Aoyama T, Francke U, Dietz HC, Furthmayr H. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest 1994: 94: 130-137.
19. Raghunath M, Kielty CM, Kainulainen K, Child A, Peltonen L, Steinmann B. Analysis of truncated fibrillin caused by a 366 bp deletion in the FBN1 gene resulting in Marfan syndrome. Biochem J 1994: 302: 889-896.